Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-26

FDA Approved: MORPHINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Morphine Sulfate from Actavis Pharma, Inc., permitting continued marketing of the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MORPHINE SULFATE (MORPHINE SULFATE)

Snippet

SUPPL AP for MORPHINE SULFATE (MORPHINE SULFATE)